M Künkel
About
In The Last Decade
M Künkel
27 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 1.1k
- Pharmacology 606
- Epidemiology 563
- Clinical Biochemistry 519
- Parasitology 368
Countries citing papers authored by M Künkel
This map shows the geographic impact of M Künkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Künkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Künkel more than expected).
Fields of papers citing papers by M Künkel
This network shows the impact of papers produced by M Künkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Künkel. The network helps show where M Künkel may publish in the future.
Co-authorship network of co-authors of M Künkel
This figure shows the co-authorship network connecting the top 25 collaborators of M Künkel. A scholar is included among the top collaborators of M Künkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Künkel. M Künkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study breakdown → | 402 |
| 2 | 18 | |
| 3 | 119 | |
| 4 | 2 | |
| 5 | 179 | |
| 6 | 165 | |
| 7 | 428 | |
| 8 | 28 | |
| 9 | 97 | |
| 10 | 283 | |
| 11 | 12 | |
| 12 | 122 | |
| 13 | 15 | |
| 14 | [Long-term results following percutaneous reanastomosis of complete ureteral occlusion]. | 1 |
| 15 | [Percutaneous pyeloplasty. Indications, technic, results]. | 5 |
| 16 | 5 | |
| 17 | 8 | |
| 18 | 24 | |
| 19 | Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups. | 3 |
| 20 | Cefotaxime failure in group A streptococcal meningitis. | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.